EUCTR2006-001785-16-SE进行中（未招募）不适用
eo-adjuvant behandling av esofagus-cardia cancer inför kurativt syftande resektion. Jämförande studie mellan kemo- och radiokemobehandling. - Neo-adjuvant behandling av esofagus-cardia cancer
适应症
试验速览
- 阶段
- 不适用
- 状态
- 进行中（未招募）
- 入组人数
- 168
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •Patients with a resectable carcinoma of the esophagus and or gastric cardia.
- •Patients with proximal tumour localision will not be included if laryngectomy is required. Patients will be randomised to either chemoteraphy alone or combined radiochemoteraphy provided that no contraindications are privaling relevant to respecitve chemoradiotherapeutic agents. Al patients will subsequently be operated in high volume centres.
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range
排除标准
- •Not recectable disease stages
- •Inoperable patients due to complicating medical disorders
- •Predictable inability to cope with the neoadjuvant treatment
- •Unwillingnes to participate
- •Childbearing age
- •Predicted uncompliance
研究者
相似试验
进行中（未招募）
1 期
PLAnning Treatment For Oesophago-Gastric Cancer: a Randomised Maintenance Therapy TrialOesophago-gastric adenocarcinomaEUCTR2014-002169-30-GBThe Royal Marsden NHS Foundation Trust770
已完成
2 期
eoadjuvant chemoradiotherapy followed by esophagectomy for REG I positive T4, N4 or many thoracic esophageal cancerthoracic esophageal cancerJPRN-UMIN000001626The Cancer Board of Esophageal Cancer in Akita University Hospital30
进行中（未招募）
不适用
TRAITEMENT NEOADJUVANT DU CANCER DE L’ŒSOPHAGE OPERABLE A VISEE CURATIVE PAR 5-FLUOROURACILE, CISPLATINE ET CETUXIMAB + RADIOTHERAPIE CONCOMITANTE. ÉTUDE DE PHASE I-II - FFCD 0505Cancer de l’œsophage avec indication d’exérèse à visée curativeEUCTR2006-004770-27-FRFédération Francophone de Cancérologie Digestive - FFCD45
进行中（未招募）
1 期
Eoadjuvant chemoradiotherapy for Esophageal squamous cell carcinoma versus Definitive chemoradiotherapy with salvage Surgery as needed (The NEEDS Trial)Resectable locally advanced squamous cell carcinoma (SCC) of the esophagusCTIS2022-500966-82-00Karolinska University Hospital1,010
进行中（未招募）
1 期
Combined chemotherapy and radiotherapy followed by planned surgery compared to combined chemotherapy and radiotherapy with surgery only when really needed, for patients with cancer in the esophagus.Resectable locally advanced squamous cell carcinoma (SCC) of the esophagusMedDRA version: 21.1Level: LLTClassification code 10025899Term: Malignant neoplasm of esophagusSystem Organ Class: 100000004864MedDRA version: 21.1Level: LLTClassification code 10025901Term: Malignant neoplasm of esophagus, unspecifiedSystem Organ Class: 100000004864EUCTR2020-000149-15-IEKarolinska University Hospital1,020